Tune in as we delve deep into the world of PARP inhibitors. Discover the secrets behind their mechanisms of action in a one-of-a-kind whiteboard animation video. Gain essential insights into patient selection criteria, and stay up to date with the latest clinical safety and efficacy data. We’ll also equip you with expert strategies to effectively manage side effects, ensuring you’re at the forefront of evidence-based, guideline-aligned prostate cancer care.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/accelerating-clinical-practice-latest-advancements-parp-inhibitors-metastatic
- Start Date: 2024-02-15 06:00:00
- End Date: 2024-02-15 06:00:00
- Credit Details: IPCE Credits: 1.0 hours
AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: Source: AstraZeneca (Any division) - Amount: 20000.0 - Is Kind Support: False Source: Merck (Any division) - Amount: 331666.67 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest